Starting Nov. 25, The Seaport will also be unveiling “moonGARDEN,” a public art installation making its NYC debut downtown.

Fintel reports that on November 5, 2024, Seaport Global initiated coverage of First Solar (NasdaqGS:FSLR) with a Neutral recommendation. Analyst Price Forecast Suggests 53.17% Upside As of October 22, ...

Plus, a northern location for Anna’s Taqueria, and wild game at Time Out Market Boston. In fast-casual news, Anna’s Taqueria ...

Six months after launching with a mega-round of financing, Seaport Therapeutics has raised $225 million more to advance a lead drug candidate that could overcome some limitations of currently ...

Snowport is back. The Holiday Market reopens in Boston this weekend. Here's how you can skip the line with a timed-entry ...

Seaport Research raised the firm’s price target on Hims & Hers to $32 from $28 and keeps a Buy rating on the shares. The company ...

Seaport Global analyst Mark Weintraub maintained a Hold rating on Louisiana-Pacific (LPX – Research Report) today. The company’s ...

Plural Investing LLC, an investment advisor, released its Q3 2024 “Plural Partners Fund L.P” investor letter. A copy of the ...

Research analysts at Seaport Res Ptn raised their Q3 2025 EPS estimates for Chart Industries in a research note issued on Monday, November 4th. Seaport Res Ptn analyst W. Liptak now anticipates that ...

If there’s ever been a time to treat yourself, it’s now. And just in time, Boston.com dropped its monthly list of new restaurants to try.

BOSTON, November 05, 2024--(BUSINESS WIRE)--Seaport Therapeutics ("Seaport or the "Company"), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a ...

International Paper (NYSE:IP – Free Report) – Equities researchers at Seaport Res Ptn issued their Q1 2025 earnings per share ...